• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号
首页- Products - Cell Cycle/DNA Damage - CDK - A-674563 HCl (552325-73-2(free base))

A-674563 HCl (552325-73-2(free base))

CAS No. 2070009-66-2

A-674563 HCl (552325-73-2(free base)) ( —— )

产品货号. M35283 CAS No. 2070009-66-2

A-674563 hydrochloride 是具有选择性的高效 Akt1 抑制剂,其 Ki 值为 11 nM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥1026 有现货
5MG ¥1292 有现货
10MG ¥1805 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥1292 有现货

生物学信息

  • 产品名称
    A-674563 HCl (552325-73-2(free base))
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    A-674563 hydrochloride 是具有选择性的高效 Akt1 抑制剂,其 Ki 值为 11 nM。
  • 产品描述
    A-674563 hydrochloride is a potent and selective Akt1 inhibitor with Ki of 11 nM.
  • 体外实验
    A-674563 slows proliferation of tumor cells with an EC50 of 0.4 μM. A563 (0-10 μM) significantly decreases GSK3 and MDM2 phosphorylation in STS cells. A563 shows inhibitory effect on all STS cell lines, with IC50 values at 48 hours ranging from 0.22±0.034 μM (SW684) to 0.35 ±0.06 μM (SKLMS1). A563 induces G2 cell cycle arrest and apoptosis in STS cells. A563 (1 μM/12 hr) upregulates the expression of GADD45A independent of p53. A-674563 (10-1000 nM) is anti-proliferative and cytotoxic in cultured human melanoma cells, induces melanoma cell apoptotic death, inhibited by caspase inhibitors, and inhibits melanoma cells via Akt-dependent and -independent mechanisms. A-674563 is cytotoxic and anti-proliferative when added to U937 and AmL progenitor cells, activates caspase-3/9 and apoptosis in U937 and AmL progenitor cells, and manipulates other signalings in AmL cells whiling blocking Akt.
  • 体内实验
    A-674563 (40 mg/kg/d, p.o.) shows no significant monotherapy activity, but the efficacy of the combination therapy (A-674563+paclitaxel) is significantly improved in the PC-3 prostate cancer xenograft model. A-674563 (20, 100 mg/kg) increases plasma insulin in an oral glucose tolerance test. A563 (20 mg/kg/bid; p.o.) exhibits slow tumor growth and a significant difference in tumor volume without significant weight loss of mice. A563-treated tumors express increased levels of GADD45α and decreased levels of PCNA (a nuclear marker for proliferation). Additionally, TUNEL assay staining levels (marker for apoptosis) increase in the A563-treated specimens. A-674563 (25, 100 mg/kg, lavage daily) potently inhibits A375 xenograft growth in mice. A-674563 (15, 40 mg/kg) injection inhibits U937 xenograft in vivo growth, and improves mice survival.
  • 同义词
    ——
  • 通路
    Cell Cycle/DNA Damage
  • 靶点
    CDK
  • 受体
    CDK | ERK | PKA | PKC | Akt
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2070009-66-2
  • 分子量
    394.9
  • 分子式
    C22H23ClN4O
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?H2O 中的溶解度 : 100 mg/mL (253.23 mM; 超声助溶) DMSO 中的溶解度 : 50 mg/mL (126.61 mM; 超声助溶 )
  • SMILES
    CC=1C=2C(=CC=C(C2)C=3C=C(OC[C@H](CC4=CC=CC=C4)N)C=NC3)NN1.Cl
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Luo Y, et al. Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo. Mol Cancer Ther, 2005, 4(6), 977-986.?
产品手册
关联产品
  • LSN2839567

    Abemaciclib metabolite M2 (LSN2839567)是 Abemaciclib 的代谢物,为有效的 CDK4 和 CDK6 抑制剂,IC50 值分别为 1.2 nM 和 1.3 nM。具有抗肿瘤活性。

  • CYC065

    CYC065 是 seliciclib 的衍生物,是第二代 CDK 抑制剂,主要作用于 CDK2/5/9。

  • T025

    T025 是口服有效的Cdc2-like 激酶 (CLK) 抑制剂,对 CLK1,CLK2,CLK3,CLK4,DYRK1A,DYRK1B 和 DYRK2 的 Kd 分别为4.8,0.096,6.5,0.61,0.074,1.5 和 32 nM。T025 诱导 caspase-3/7 介导的细胞凋亡 (apoptosis)。T025 可降低 CLK 依赖性磷酸化。T025 在血液和实体癌细胞系中均具有抗增殖活性 (IC50值:30-300 nM)。T025 具有抗肿瘤功效,主要用于MYC驱动的疾病研究。